IRIS
Zambelli, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.309
EU - Europa 657
AS - Asia 355
AF - Africa 143
OC - Oceania 12
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 6
Totale 2.493
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.305
FI - Finlandia 184
SG - Singapore 176
NG - Nigeria 143
CN - Cina 126
IE - Irlanda 124
DE - Germania 87
FR - Francia 64
GB - Regno Unito 50
IT - Italia 48
NL - Olanda 31
IN - India 29
SE - Svezia 22
RU - Federazione Russa 14
AU - Australia 12
HK - Hong Kong 8
CL - Cile 7
CZ - Repubblica Ceca 7
JP - Giappone 6
A2 - ???statistics.table.value.countryCode.A2??? 5
BE - Belgio 4
CA - Canada 4
ES - Italia 4
PL - Polonia 3
BR - Brasile 2
CH - Svizzera 2
KR - Corea 2
NO - Norvegia 2
RO - Romania 2
UA - Ucraina 2
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
CO - Colombia 1
CY - Cipro 1
DK - Danimarca 1
EU - Europa 1
GR - Grecia 1
IR - Iran 1
JO - Giordania 1
MD - Moldavia 1
MK - Macedonia 1
MY - Malesia 1
NP - Nepal 1
PK - Pakistan 1
QA - Qatar 1
SI - Slovenia 1
TW - Taiwan 1
Totale 2.493
Salva come PNG Salva come JPEG
Città #
Chandler 208
Helsinki 184
New York 159
Benin City 143
Dublin 124
Singapore 124
Shanghai 120
Lawrence 113
Princeton 113
Ashburn 94
Wilmington 76
Boardman 62
Paris 56
London 35
Amsterdam 29
San Mateo 29
Ann Arbor 16
Fairfield 15
Leawood 13
Los Angeles 13
Phoenix 11
Milan 9
Florence 8
Woodbridge 8
Mumbai 7
Pune 7
Evanston 6
Moscow 6
Norwalk 6
Brno 5
Cincinnati 5
Falkenstein 5
Heidelberg 5
Santa Clara 5
Seattle 5
Bergamo 4
Bologna 4
Brussels 4
Frankfurt am Main 4
Hanover 4
Munich 4
Novokuznetsk 4
Barcelona 3
Berlin 3
Cupertino 3
Darang 3
Gunzenhausen 3
Melbourne 3
Rome 3
Tampa 3
Ahmedabad 2
Barnaul 2
Bradford 2
Casoria 2
Chennai 2
Chester 2
Clearwater 2
Denver 2
Glasgow 2
Grafton 2
Gwangju 2
Hangzhou 2
Hooversville 2
La Canada Flintridge 2
Napoli 2
Navi Mumbai 2
Röllbach 2
Saint Louis 2
San Diego 2
Sha Tin Wai 2
Shinjuku 2
São Paulo 2
Villeneuve-le-Roi 2
Warrensburg 2
Warwick 2
Washington 2
Aberdeen 1
Alexandria 1
Amman 1
Athens 1
Belovo 1
Bitola 1
Boston 1
Brisbane 1
Buenos Aires 1
Central 1
Chisinau 1
Davis 1
Dearborn 1
Den Haag 1
Doha 1
Esfahan 1
Henderson 1
Highland Park 1
Hillsboro 1
Kathmandu 1
Kingston 1
Las Vegas 1
Lexington 1
Liverpool 1
Totale 1.952
Salva come PNG Salva come JPEG
Nome #
Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants 98
Antitumour activity of trabectedin in myelodysplastic/myeloproliferative neoplasms 58
Breast and renal cancer-Derived endothelial colony forming cells share a common gene signature 56
ACUTE UPPER GASTROINTESTINAL BLEEDING (AUGB) IN ITALY: AN INTERIM ANALYSIS OF THE ORGANIZATIONAL ASPECTS CARING AN EVOLVING DISEASE 50
Predicting and preventing cardiotoxicity in the era of breast cancer targeted therapies. Novel molecular tools for clinical issues. 49
34. Trabectedin and indole-3-carbinol combination in heavily pretreated metastatic breast cancer: Results of a pilot clinical study 48
Clinical portrait of the SARS-CoV-2 epidemic in European cancer patients 45
TRANSFUSION STRATEGY AND DEATH RISK IN PATIENTS WITH ACUTE NON-VARICEAL UPPER GASTRO INTESTINAL BLEEDING (NV-UGIB) IN ITALY: A PROSPECTIVE MULTICENTER OBSERVATIONAL STUDY 40
PREDICTIVE FACTORS OF MORTALITY IN ACUTE GASTROINTESTINAL BLEEDING IN ITALY (AUGIB): A NEW PRE-ENDOSCOPY PROGNOSTIC MODEL FROM A MULTICENTER STUDY 38
OUTPATIENT MANAGEMENT OF PATIENTS WITH GLASGOW-BLATCHFORD BLEEDING SCORE LOW-RISK UPPER-GASTROINTESTINAL HEMORRHAGE: A MULTICENTER VALIDATION STUDY IN ITALY 37
From cancer patients to cancer survivors: the issue of Cardioncology--a biological perspective. 37
Ado-trastuzumab emtansine (T-DM1) in HER2+ advanced breast cancer patients: does pretreatment with pertuzumab matter? 37
SAFETY PROFILE AND TOLERABILITY OF 'TRABECTEDIN AND INDOLE-3-CARBINOL COMBINATION IN REFRACTORY ADVANCED BREAST CANCER. PRELIMINARY RESULTS OF PHASE 1 CLINICAL STUDY 35
Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe: results from the retrospective, multicentre, OnCovid registry study 34
Adding pertuzumab to adjuvant therapy for high-risk HER2-positive early breast cancer in APHINITY: a GRADE analysis 34
Multinational characterization of neurological phenotypes in patients hospitalized with COVID-19 34
Adipose-derived mesenchymal stem cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling 33
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 32
ONCO-i2b2: Improve Patients Selection through Case-Based Information Retrieval TechniquesData Integration in the Life Sciences 31
Allogeneic blood stem cell transplantation after a reduced-intensity, preparative regimen - A pilot study in patients with refractory malignancies 30
Remodelling of the Ca2+ signalling machinery in endothelial progenitor cells isolated from breast cancer patients 30
Analysis of SEMA6B gene expression in breast cancer: Identification of a new isoform 30
MORTALITY IN UPPER GASTROINTESTINAL BLEEDING IN ITALY: DATA FROM NATIONAL SURVEY 29
Alternative Splicing in Adhesion- and Motility-Related Genes in Breast Cancer 29
Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection: evidence from the OnCovid retrospective, multicentre registry study 28
A randomized multicenter study of optimal circadian time of vinorelbine combined with chronomodulated 5-fluorouracil in pretreated metastatic breast cancer patients: EORTC trial 05971 28
Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score 27
Allogeneic haematopoietic stem cell transplantation for metastatic renal carcinoma in Europe 27
Absence of the K303R estrogen receptor alpha mutation in breast cancer patients exhibiting different responses to aromatase inhibitor anastrozole neoadjuvant treatment 27
AurkA controls self-renewal of breast cancer-initiating cells promoting wnt3a stabilization through suppression of miR-128 26
T-cell dynamics after high-dose chemotherapy in adults: elucidation of the elusive CD8(+) subset reveals multiple homeostatic T-cell compartments with distinct implications for immune competence 25
T-DM1 and brain metastases: Clinical outcome in HER2-positive metastatic breast cancer 25
An ICT infrastructure to integrate clinical and molecular data in oncology research 25
PONDx: real-life utilization and decision impact of the 21-gene assay on clinical practice in Italy 25
A Remote Monitoring System to Optimize the Home Management of Oral Anticancer Therapies (ONCO-TreC): Prospective Training-Validation Trial 25
COVID-19 Sequelae and the Host Pro-Inflammatory Response: An Analysis From the OnCovid Registry 23
Circulating CD33+large mononuclear cells contain three distinct populations with phenotype of putative antigen-presenting cells including myeloid dendritic cells and CD14+monocytes with their CD16+subset 23
Analysis of Italian BRCA1/2 Pathogenic Variants Identifies a Private Spectrum in the Population from the Bergamo Province in Northern Italy 23
From seaside to bedside: Current evidence and future perspectives in the treatment of breast cancer using marine compounds 22
Cellular and molecular determinants of all‐ trans retinoic acid sensitivity in breast cancer: Luminal phenotype and α expression 22
trattamento conservativo dell' osteonecrosi spontaea del ginocchio in fase iniziale con campi pulsati: studio a 2 anni di follow-up minimo 22
Clinical toxicity of cryopreserved circulating progenitor cells infusion 22
Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874) 21
An epirubicin/paclitaxel combination mobilizes large amounts of hematopoietic progenitor cells in patients with metastatic breast cancer showing optimal response to the same chemotherapy regimen 21
A Network-Based Data Integration Approach to Support Drug Repurposing and Multi-Target Therapies in Triple Negative Breast Cancer 21
A male patient with acromegaly and breast cancer: treating acromegaly to control tumor progression 21
Cellular and molecular determinants of breast cancer sensitivity to all-trans retinoic acid: Identification of a gene expression fingerprint predicting responsiveness 20
Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective 20
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 20
Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study 19
Time-Dependent COVID-19 Mortality in Patients With Cancer: An Updated Analysis of the OnCovid Registry 19
Resistance to platinum-based chemotherapy is associated with epithelial to mesenchymal transition in epithelial ovarian cancer 19
Clinical and pathological factors predicting long-term disease control with lapatinib and capecitabine for patients with HER2 positive metastastic breast cancer: results from a multicenter retrospective study 18
Editorial: Trabectedin, lurbinectedin, and other marine-derived anticancer alkaloids on solid cancer: Mechanisms of action, clinical impact, and future perspectives 17
Four-day infusion of fluorouracil plus vinorelbine as salvage treatment of heavily pretreated metastatic breast cancer 17
Prolyl-isomerase Pin1 controls normal and cancer stem cells of the breast 17
Immunotherapy for HER2-Positive Breast Cancer: Clinical Evidence and Future Perspectives 16
Cytotoxic chemotherapy preceding apheresis of peripheral blood progenitor cells can affect the early reconstitution phase of naive T cells after autologous transplantation 16
Clinical Review on the Management of Breast Cancer Visceral Crisis 15
Gene expression profiling and prediction of response to hormonal neoadjuvant treatment with anastrozole in surgically resectable breast cancer 15
Incidence of human cytomegalovirus infection in patients with refractory solid tumors receiving nonmyeloablative allogeneic stem cell transplants versus recipients of standard SCT for hematologic malignancies 15
Is There Still a Role for Endocrine Therapy Alone in HR+/HER2- Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulvestrant as First-Line Therapy in the Real-World Setting: The EVA and GIM-13 AMBRA Studies 15
Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy 15
Two Missense Variants Detected in Breast Cancer Probands Preventing BRCA2-PALB2 Protein Interaction 15
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 15
No correlation between plasma D-dimer levels and lymph node involvement in operable breast cancer 15
Prospective multicenter quality assessment of endotherapy of biliary stones: does center volume matter? 15
Hodgkin's disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma 14
Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow 14
Management and Survival of Pleural Mesothelioma: A Record Linkage Study 14
Trabectedin for the treatment of breast cancer 14
Profiling cancer gene mutations in longitudinal epithelial ovarian cancer biopsies by targeted next-generation sequencing: a retrospective study 14
Heterogeneity of triple-negative breast cancer: understanding the Daedalian labyrinth and how it could reveal new drug targets 13
Controversies and Opportunities in the Clinical Daily Use of the 21-Gene Assay for Prognostication and Prediction of Chemotherapy Benefit in HR+/HER2- Early Breast Cancer 13
The Role of Female Reproductive Hormones in the Association between Migraine and Breast Cancer: An Unanswered Question 13
Erratum: Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9 (31877-31887) DOI: 10.18632/oncotarget.25874) 13
Pilot study of the mechanism of action of preoperative trastuzumab in patients with primary operable breast tumors overexpressing HER2 13
Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation 13
Phase II study with ifosfamide, carboplatin, etoposide (ICE regimen) at intermediate dosage for advanced non small cell lung cancer (NSCLC) 13
Epithelial tumour cell detection and the unsolved problems of nested RT-PCR: A new sensitive one step method without false positive results 13
Free mobility of medical oncologists across the European Union: still a false myth 13
Pulmonary function and complications following chemotherapy and stem cell support in breast cancer 13
Multi-institutional retrospective analysis of clinical and pathological factors predicting resistance to lapatinib-based therapy in HER2 positive metastatic breast cancer (HER2+ MBC) 13
What Every Reader Should Know About Studies Using Electronic Health Record Data but May Be Afraid to Ask 13
Promises and Challenges of Adult Stem Cells in Cancer Therapy 13
Targeting triple negative breast cancer: Is p53 the answer? 13
Long-term survival in patients with metastatic breast cancer receiving intensified chemotherapy and stem cell rescue: data from the Italian registry 13
Short commentaries on data published by Petit et al. on locoregional risk after lipofilling in breast cancer patients 13
COVID-19 in breast cancer patients: a subanalysis of the OnCovid registry 13
Opportunities and Challenges of Synthetic Data Generation in Oncology 12
Erlotinib administration for advanced non-small cell lung cancer during the first 2 months of unrecognized pregnancy 12
STEM-CELL FACTOR AND INTERLEUKIN-6, ALONE OR IN COMBINATION WITH GRANULOCYTE-COLONY-STIMULATING FACTOR, DO NOT AFFECT THE GROWTH OF SOLID TUMOR-CELL LINES 12
Evaluation of infectious complications and immune recovery following high-dose chemotherapy (HDC) and autologous peripheral blood progenitor cell transplantation (PBPC-T) in 148 breast cancer patients 12
Everolimus (EVE) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: new lessons for clinical practice from the EVA study 12
Proteasome machinery is instrumental in a common gain-of-function program of the p53 missense mutants in cancer 12
High-dose chemotherapy and autologous hematopoietic stem cell transplantation as adjuvant treatment in high-risk breast cancer: data from the EBMT registry 1995-2005 12
Long-term survival in a fraction of patients with metastatic breast cancer who received consolidation therapy with high-dose chemotherapy and autologous stem cell transplant between 2000 and 2015: an EBMT registry-based study 12
Regulation of aromatase expression in breast cancer treated with anastrozole neoadjuvant therapy 12
Loco-Regional Treatment of the Primary Tumor in De Novo Metastatic Breast Cancer Patients Undergoing Front-Line Chemotherapy 11
Prospective observational study on the impact of the 21-gene assay on treatment decisions and resources optimization in breast cancer patients in Lombardy: The BONDX study 11
Totale 2.277
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.225
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.225
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201 0 0 0 0 0 0 0 0 0 0 0 1
2020/2021135 0 1 2 0 6 40 12 14 28 17 3 12
2021/2022480 4 1 4 17 5 6 7 12 184 82 138 20
2022/20231.037 247 47 134 82 96 59 5 52 95 140 63 17
2023/20241.008 70 78 158 47 36 195 54 46 27 31 101 165
2024/202514 14 0 0 0 0 0 0 0 0 0 0 0
Totale 2.675